Drug combo for lung disease gets safety check in healthy volunteers
NCT ID NCT07173738
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed Phase 1 study looked at how two drugs, BIA 5-1058 and furosemide, affect each other when taken together. 44 healthy adults received each drug alone and then together, under fasting conditions. The goal was to measure drug levels and safety, not to treat any disease. This information will help guide future studies for pulmonary arterial hypertension.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BIA 5-1058 and furosemide
What this could lead to
If successful, this study will show how these two drugs interact, helping design safer combination treatments for pulmonary arterial hypertension.
What could go wrong
This is an early Phase 1 study in healthy people, not patients. It only measures drug levels and safety, not whether the combination actually helps treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Simbec Research Ltd (Simbec)
Merthyr Tydfil, CF48 4DR, United Kingdom